Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glomerular filtrate proteins in acute cardiorenal syndrome
Rumie Wakasaki, … , Paul D. Piehowski, Michael P. Hutchens
Rumie Wakasaki, … , Paul D. Piehowski, Michael P. Hutchens
Published February 21, 2019
Citation Information: JCI Insight. 2019;4(4):e122130. https://doi.org/10.1172/jci.insight.122130.
View: Text | PDF
Research Article Cardiology Nephrology

Glomerular filtrate proteins in acute cardiorenal syndrome

  • Text
  • PDF
Abstract

Acute cardiorenal syndrome (CRS-1) is a morbid complication of acute cardiovascular disease. Heart-to-kidney signals transmitted by “cardiorenal connectors” have been postulated, but investigation into CRS-1 has been limited by technical limitations and a paucity of models. To address these limitations, we developed a translational model of CRS-1, cardiac arrest and cardiopulmonary resuscitation (CA/CPR), and now report findings from nanoscale mass spectrometry proteomic exploration of glomerular filtrate 2 hours after CA/CPR or sham procedure. Filtrate acquisition was confirmed by imaging, molecular weight and charge distribution, and exclusion of protein specific to surrounding cells. Filtration of proteins specific to the heart was detected following CA/CPR and confirmed with mass spectrometry performed using urine collections from mice with deficient tubular endocytosis. Cardiac LIM protein was a CA/CPR-specific filtrate component. Cardiac arrest induced plasma release of cardiac LIM protein in mice and critically ill human cardiac arrest survivors, and administration of recombinant cardiac LIM protein to mice altered renal function. These findings demonstrate that glomerular filtrate is accessible to nanoscale proteomics and elucidate the population of proteins filtered 2 hours after CA/CPR. The identification of cardiac-specific proteins in renal filtrate suggests a novel signaling mechanism in CRS-1. We expect these findings to advance understanding of CRS-1.

Authors

Rumie Wakasaki, Katsuyuki Matsushita, Kirsti Golgotiu, Sharon Anderson, Mahaba B. Eiwaz, Daniel J. Orton, Sang Jun Han, H. Thomas Lee, Richard D. Smith, Karin D. Rodland, Paul D. Piehowski, Michael P. Hutchens

×

Figure 5

Cardiac LIM protein originates outside the kidney in cardiac arrest and transits from plasma to tubular epithelial cells.

Options: View larger image (or click on image) Download as PowerPoint
Cardiac LIM protein originates outside the kidney in cardiac arrest and ...
(A) Plasma cardiac LIM protein (CSRP3) levels are greatly increased 24 hours after CA/CPR but not 24 hours after renal-only ischemia, induced by renal pedicle clamping. (B) Tubular detection of cardiac LIM protein by immunohistochemistry is specific to CA/CPR. Cardiac LIM protein was not detected after sham procedure but was present in tubular epithelial cells 24 hours after CA/CPR in wild-type, endocytosis-intact mice; it concentrated at the brush border and within some tubular cells in endocytosis-deficient mice. Representative of 3 experiments per genotype. Scale bars: 50 μm. (C) CSRP3 is not expressed in the kidney in surgically naive mice or 24 hours after CA/CPR. Shown are the number of cycles of PCR required to detect PCR product of CSRP3- or thiazide-sensitive sodium/chloride cotransporter (NCC, SCL12a3), a kidney-specific gene. Lower numbers of cycles denote increased levels of expression. CSRP3 was not detected in kidney (*ND45, not detected after 45 cycles of PCR), while SLC12a3 was easily detected in kidney. CSRP3 was readily detected in heart tissue, while SLC12a3 was not. (D) Critically ill human survivors of cardiac arrest and cardiopulmonary resuscitation, 23.9 ± 5.9 hours after CA, demonstrate mean plasma CSRP3 comparable to that of CA/CPR mice, which was elevated compared with reference human value (22). (E) 28 days after administration of CSRP3 to healthy, wild-type mice, GFR was reduced. (F) Tubulointerstitial αSMA was increased and (G) urine albumin was also increased, indicating that CSRP3 administration negatively affects renal function in a manner consistent with early chronic kidney disease. (A and E–F) Mean ± SEM displayed. (A) P value was calculated ANOVA with Sidak’s test. (E and F) P values were calculated using Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts